Iveric Bio Inc Reports Results For The Quarter Ended In September: Earnings Summary

IVERIC bio

03/11/2022 13:32

* IVERIC bio Inc  ISEE.OQ  reported a quarterly adjusted
loss
of 35 cents​​ per share for the quarter ended in September. The
mean expectation of ten analysts for the quarter was for a loss
of 40 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * IVERIC bio Inc's reported EPS for the quarter was a loss
of 35
cents​.
    * The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * IVERIC bio Inc shares had risen by 27.3% this quarter and
gained 36.6% so far this year.
    * The company reported a quarterly loss of $42.35 million.
    * Wall Street's median 12-month price target for IVERIC bio
Inc is
$29.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 01:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.40          -0.35          Beat
 Jun. 30 2022      -0.31          -0.41          Missed
 Mar. 31 2022      -0.29          -0.29          Met
 Dec. 31 2021      -0.25          -0.29          Missed